Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 1000-1009

  Yu, Sheu Meei ^a   Chen, Sheue Fang ^a   Lau, Ying Tung ^a   Yang, Chuen Mao ^a   Chen, Jin Chung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RAF PROTEIN; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; GROWTH STIMULATION; MITOGENESIS; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL COUNT; CELL DIVISION; CELLS, CULTURED; DNA; ENZYME ACTIVATION; EXTRACELLULAR SPACE; GTP-BINDING PROTEINS; LEUCINE; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL; THYMIDINE; TRANSCRIPTION FACTORS; TRITIUM;

EID: 0029979741     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ross, R. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314:488-500 (1986).
2. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond.) 362:801-809 (1993).
3. Gordon, J. L. Extracellular ATP: effects, sources and fate. Biochem. J. 233:309-319 (1986).
4. Burnstock, G., and C. Kennedy. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone: excitatory cotransmitter with noradrenaline from perivascular nerves and locally release inhibitory intravascular agent. Circ. Res. 88:319-330 (1986).
5. Olsson, R. A., and J. D. Pearson. Cardiovascular purinoceptors. Physiol. Rev. 70:761-845 (1990).
6. Huang, N. N., D. J. Wang, and L. A. Heppel. Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. Proc. Natl. Acad. Sci. USA 86:7904-7908 (1989).
7. Huang, N. N., D. J. Wang, F. A. Gonzalez, and L. A. Heppel. Multiple signal transduction pathways lead to extracellular ATP-stimulated mitogenesis in mammalian cells. II. A pathway involving arachidonic acid release, prostaglandin synthesis, and cyclic AMP accumulation. J. Cell. Physiol. 146:483-494 (1991).
8. Wang, D. J., N. N. Huang, F. A. Gonzalez, and L. A. Heppel. Multiple signal transduction pathways lead to extracellular ATP-stimulated mitogenesis in mammalian cells. I. Involvement of protein kinase C-dependent and -independent pathways. J. Cell. Physiol. 146:473-482 (1991).
9. Huwiler, A., and J. Pfeilschifter. Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J. Pharmacol. 113:1455-1463 (1994).
10. Inscho, E. W., K. D. Mitchell, and L. G. Navar. Extracellular ATP in the regulation of renal microvascular function. FASEB J. 8:319-328 (1994).
11. Crowley, S. T., E. C. Dempsey, K. B. Horwitz, and L. D. Horwitz. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation 90:1908-1918 (1994).
12. 2x-purinoceptor. Br. J. Pharmacol. 90:383-391 (1987).
13. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci. 16:133-138 (1995).
14. Pouyssegur, J., and K. Seuwen. Transmembrane receptors and intracellular pathways that control cell proliferation. Annu. Rev. Physiol. 54:195-210 (1992).
15. Davis, R. J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556 (1993).
16. Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science (Washington D. C.) 260:315-319 (1993).
17. Yu, S. M., S. Y. Tsai, J. H. Guh, F. N. Ko, C. M. Teng, and J. T. Ou. Mechanisms of catecholamine-induced vascular smooth muscle cell proliferation. Circulation 94:547-554 (1996).
18. Blenis, J. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889-5892 (1993).
19. Leevers, S. J., and C. J. Marshall. MAP kinase regulation: the oncogene connection. Trends Cell Biol. 2:283-286 (1992).
20. Yu, S. M., Z. J. Cheng, and S. C. Kuo. Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat. Br. J. Pharmacol. 114:1227-1235 (1995).
21. Ko, F. N., S. M. Yu, Y. F. Kang, and C. M. Teng. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat. Br. J. Pharmacol. 116:1801-1808 (1995).
22. 1 in mammalian fibroblasts. Science (Washington D. C.) 259:1908-1911 (1993).
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
24. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J. Biol Chem. 269:5693-5698 (1994).
25. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
26. 2-purinoceptor subtypes in human small pulmonary arteries. Br. J. Pharmacol. 98:1014-1020 (1989).
27. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol. 30:312-313 (1978).
28. Thomas, G. MAP kinase by any other name smells just as sweet. Cell 68:3-6 (1992).
29. Seth, A., F. A. Gonzalez, S. Gupta, D. L. Raden, and R. J. Davis. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:24796-24804 (1992).
30. Erlinge, D., H. Yoo, L. Edvinsson, D. J. Reis, and C. Wahlestedt. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol. 265:H1089-H1097 (1993).
31. Ip, J. H., V. Fuster, L. Badimon, J. Badimon, M. B. Tauman, and J. H. Chesebro. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 15:1667-1687 (1990).
32. 2Y-purinoceptor-stimulated surfactant phospholipid secretion from isolated alveolar type II cells. Br. J. Pharmacol. 97:158-162 (1989).
33. 2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J. Cell. Physiol. 166:57-65 (1996).
34. Schorb, W., G. W. Booz, D. E. Dostal, K. M. Conrad, K. C. Chang, and K. M. Baker. Angiotensin II is mitogen in neonatal rat cardiac fibroblasts. Circ. Res. 72:1245-1254 (1993).
35. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J. Clin. Invest. 83:708-712 (1989).
36. Tobe, K., T. Kadowaki, H. Tamemoto, K. Ueki, K. Hara, O. Koshio, K. Momomura, Y. Gotoh, E. Nishida, Y. Akanuma, Y. Yazaki, and M. Kasuga. Insulin and 12-O-tetradecanoylphorbol-13-acetate activation of two immunologically distinct myelin basic protein/microtubule-associated protein 2 (MBP/MAP2) kinases via de novo phosphorylation of threonine and tyrosine residues. J. Biol. Chem. 266:24793-24803 (1991).
37. Granot, Y., E. Erikson, H. Fridman, V. V. Putten, B. Williams, R. W. Schrier, and J. L. Maller. Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase byvasopressin in cultured rat vascular smooth muscle cells. J. Biol. Chem. 268:9564-9569 (1993).
38. Nishida, E., and Y. Gotoh. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18:128-131 (1993).
39. mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 5:845-854 (1992).
40. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Miachak, G. Finkenzeller, D. Marme, and U. R. Rapp. Protein kinase Ca activates Raf-1 by direct phosphorylation. Nature (Lond.) 364:249-252 (1993).
41. Karin, M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6:2581-2590 (1992).
42. Graves, L. M., K. E. Bornfeldt, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinasedependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 271:505-511 (1996).